To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Headway snaps up six Viveris portfolio companies
The Coller Capital spin-out has purchased six minority stakes in biotech and tech companies via its recently closed €150m secondaries fund.
